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Abstract
Tendinopathy is a common and progressive musculoskeletal disease. Increased apoptosis is an end-stage 
tendinopathy manifestation, but its contribution to the pathology of the disease is unknown. A previously 
established in vivo model of fatigue-damage accumulation shows that increased apoptosis is correlated with 
the severity of induced tendon damage, even in early onset of the disease, supporting its implication in the 
pathogenesis of the disease. Consequently, this study aimed to determine: (1) whether apoptosis could be 
inhibited after fatigue damage and (2) whether its inhibition could lead to remodeling of the extracellular 
matrix (ECM) and pericellular matrix (PCM), to ultimately improve the mechanical properties of fatigue-
damaged tendons. The working hypothesis was that, despite the low vascular nature of the tendon, apoptosis 
would be inhibited, prompting increased production of matrix proteins and restoring tendon mechanical 
properties. Rats received 2 or 5 d of systemic pan-caspase inhibitor (Q-VD-OPh) or dimethyl sulfoxide (DMSO) 
carrier control injections starting immediately prior to fatigue loading and were sacrificed at days 7 and 14 
post-fatigue-loading. Systemic pan-caspase inhibition for 2 d led to a surprising increase in apoptosis, but 
inhibition for 5 d increased the population of live cells that could repair the fatigue damage. Further analysis 
of the 5 d group showed that effective inhibition led to an increased population of cells producing ECM 
and PCM proteins, although typically in conjunction with oxidative stress markers. Ultimately, inhibition 
of apoptosis led to further deterioration in mechanical properties of fatigue-damaged tendons.
Keywords: Cells, tissues, ligament, tendon, extracellular matrix collagens, connective tissues, tendon, cells/
tissues-aging/apoptosis, animal models.
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Introduction
Tendinopathy is a common and progressive 
musculoske le ta l  condi t ion  and accounts 
for approximately 30 % of all musculoskeletal 
consultations (McCormick et al., 1995). Effective 
therapeutics have not been developed because the 
mechanisms that underlie the pathology of these 
injuries are largely unknown. Degenerative changes 
observed in clinical samples of late-stage tendinopathy 
suggest that damage accumulation due to overuse 
underlies the pathology (Jarvinen et al., 1997; Kannus 
and Jozsa, 1991; Tallon et al., 2001). Interestingly, the 
onset of sub-rupture fatigue injury causes a decrease 
in stiffness and an increase in structural damage 
that is not recoverable, predisposing the tendon to 
accumulation of further injury, even early in the 
pathogenesis of the tendinopathy (Andarawis-Puri 
and Flatow, 2011). While the biological mechanisms 
that drive this impaired repair response are largely 
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unknown, several studies implicate apoptosis, or 
programmed cell death, as a potential contributor 
to the pathology (Benson et al., 2010; Lian et al., 2007; 
Lundgreen et al., 2011; Tuoheti et al., 2005; Wu et al., 
2011).
 Late-stage tendinopathy is characterized by 
increased apoptotic activity in conjunction with 
degenerative changes (Benson et al., 2010; Lian et 
al., 2007; Lundgreen et al., 2011; Tuoheti et al., 2005; 
Wu et al., 2011). For instance, biopsies from athletes 
with painful patellar tendinopathy exhibit increased 
apoptosis and glycosaminoglycans and collagen 
disorganization (Lian et al., 2007). Similarly, small to 
massive supraspinatus tendon tears exhibit increased 
apoptosis (Benson et al., 2010; Lundgreen et al., 2011). 
Lastly, the extent of apoptosis positively correlates 
with increased fiber disorganization in rotator cuff 
tears (Wu et al., 2011). While insightful, these studies 
do not implicate apoptosis in the pathogenesis of 
the disease since the observed increase could solely 
be a manifestation of the end disease and not part 
of its mechanistic pathogenesis. However, induced 
damage positively correlates with increased apoptotic 
activity and diminished repair response (Andarawis-
Puri et al., 2014), as shown by using a previously 
established in vivo rat patellar tendon fatigue-damage 
model of early-stage tendinopathy (Andarawis-Puri 
et al., 2012b; Fung et al., 2010).
 Diminished repair response in fatigue-damaged 
tendons could be mitigated by inhibiting apoptosis 
and, thus, increasing the population of cells available 
that could repair the damaged matrix. Previous 
studies suggest that cells in fatigue-damaged tendons 
likely undergo apoptosis in response to changes in 
their micromechanical environment that results from 
extracellular matrix (ECM) damage. The pericellular 
matrix, which is composed of proteins such as 
collagen VI and hyaluronan, is a key contributor 
to the micromechanical environment of the cells, 
as described in chondrocytes (Guilak et al., 2006). 
Interestingly, collagen VI and hyaluronan play a 
protective role against apoptosis and oxidative 
damage (Cescon et al., 2015; Peters et al., 2011; Presti 
and Scott, 1994). Furthermore, ECM damage and 
changed micromechanical environment due to 
pericellular matrix (PCM) alteration may alter cell 
fate, e.g. cell survival and apoptosis.
 Thus, the working hypothesis was that preventing 
cells in damaged matrix from undergoing apoptosis 
would prompt cells to stabilize their micromechanical 
environment through an increase in PCM proteins 
and promote an increased anabolic ECM production, 
ultimately leading to recovery of mechanical 
properties of fatigue-damaged tendons. Given the 
hypovascular nature of tendons, the first objective 
was to determine whether apoptosis was preventable 
using a systemic pan caspase inhibitor (quinolyl-valyl-
O-methylaspartyl-[-2, 6-difluorophenoxy]-methyl 
ketone, Q-VD-OPh). Then, if effective inhibition of 
apoptosis was achieved, the second objective was 
to determine whether a larger population of cells 
produced key ECM and PCM proteins, suggesting 
stabilization of their microenvironment and leading 
to improvement in mechanical properties of sub-
rupture fatigue-damaged tendons.
Materials and Methods
Under Institutional Animal Care and Use Committee 
(IACUC) approval, left patellar tendons (PT) of 74 
anesthetized (isoflurane gas: 1-5 % volume, 0.4 L/
min) 9-month-old female retired-breeder Sprague-
Dawley rats (Charles River Laboratories Inc. and 
Harlan Laboratories Inc.) were fatigue-loaded as 
per established protocols (Andarawis-Puri et al., 
2012a; Andarawis-Puri et al., 2012b; Andarawis-
Puri et al., 2014; Andarawis-Puri and Flatow, 2011; 
Bell et al., 2015; Fung et al., 2010). Sengupta (2013) 
suggests that a 9-month female subjected to fatigue 
load is comparable to a middle 20s human, which 
is a reasonable time to investigate mechanisms that 
underlie initiation and pathogenesis of chronic 
tendinopathies. Briefly, under aseptic conditions, 
the tibia and patella were exposed, clamped and 
positioned at ~ 30° flexion. The tibial clamp was 
secured in a fixed base and the patellar clamp was 
serially connected to a 222 N load cell (Transducer 
Techniques, Temecula, CA, USA) and an Instron 
machine (Instron 8841). Animals were fatigue-loaded 
for 7200 cycles from 1 to 40 N at 1 Hz. Diagnostic 
tests were applied prior to  (DT1) and post (DT2) 
fatigue loading by cycling between 1 and 15 N at 
1 Hz for 420 or 120 cycles, respectively. Damage 
parameters (Andarawis-Puri et al., 2012a; Andarawis-
Puri et al., 2012b), including hysteresis, loading and 
unloading stiffness and elongation, calculated from 
the change between DT1 and DT2, confirmed that 
all groups were similarly damaged. Skin lacerations 
were sutured with prolene 6-0 sutures (Ethicon) and 
animals resumed cage activity. Analgesic, 0.06 mg/
mL/kg buprenorphine, was injected subcutaneously 
following fatigue loading and 24 h later. While 
buprenorphine is not expected to affect cell survival, 
metabolism or apoptosis (Santiago et al., 2009), 
any confounding effects from unexpected adverse 
effects of buprenorphine were mitigated since all 
animals [both receiving the apoptosis inhibitor and 
the dimethyl sulfoxide (DMSO) control] received 
the analgesic. Sham surgeries, wherein the same 
surgical protocol is utilized for fatigue loading 
without application of the fatigue loading protocol, 
are reported in previous studies (Fung et al., 2010) 
and are found to lead to no differences from naïve 
tendons.
 Prior to fatigue loading, animals were randomly 
prescribed one of four injection regimens (n = 6-8/
group): either 2 or 5 d of apoptosis inhibitor Q-VD-
OPh (SM Biochemicals LLC, Anaheim, CA, USA) 
(20 mg/kg/d divided in 2 doses every 12 h; 4 and 10 
doses respectively) dissolved in DMSO (14.1 M at 
> 99.5 % purity) or DMSO carrier control delivered 
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by intraperitoneal injection. DMSO-injected fatigue-
loaded rats were used as controls to account for the 
possible cytotoxic effects of DMSO. The first injection 
was administered at the time of fatigue loading due 
to the systemic nature of the intraperitoneal injection 
delivery and the fact that apoptosis likely initiates 
during the 2 h of fatigue loading (Cardoso et al., 2009). 
The sample size was determined based on a previous 
study (Andarawis-Puri et al., 2014) and from an a 
priori analysis to achieve a power of 0.80.
 Animals were sacrificed at day 7 or 14 post-fatigue-
loading and the quadriceps-patellar-PT-tibia units 
were harvested, placed under ~ 2 N tension, fixed in 
Z-fix (Anatech LTD, Battle Creek, MI, USA), decalcified 
in formic acid (Decal Chemical Corporation, Tallman, 
NY, USA), embedded in paraffin and cut in 6 μm-
thick sagittal sections. Apoptosis peaks within the 
first 2 weeks after fatigue loading (Andarawis-Puri 
et al., 2014), therefore, the effect of its inhibition 
on protein production were evaluated within that 
time course. To address whether apoptosis was 
preventable using a systemic pan caspase inhibitor, 
immunohistochemistry (IHC) for cleaved caspase-3 
(1 : 1500; Cell Signaling Technologies) was conducted 
in all groups to determine effectiveness of 2 and 5 d 
of systemic apoptotic inhibition. To address whether 
a larger population of cells produced key ECM 
and PCM proteins, groups where apoptosis was 
successfully inhibited were stained for ECM proteins 
[procollagen I (1 : 100; Santa Cruz Biotechnology) 
and procollagen II (1 : 500; Biobyrt, San Francisco, 
CA, USA)], PCM proteins [collagen VI (1 : 2000; 
Abcam) and hyaluronan (1 : 200; MyBiosource, 
San Diego, CA, USA)] and oxidative stress markers 
[lysyl oxidase (LOX) (1 : 4000; Abcam) and reactive 
oxygen species modulator 1 (ROMO1) (1 : 100; Santa 
Cruz Biotechnology)]. Endogenous peroxidase 
activity was quenched using 10 % H2O2 followed by 
antigen retrieval using DeCal Retrieval Solution for 
cleaved caspase-3 (Biogenex, Freemont, CA, USA) 
and proteinase-K (Dako) for all other stains. Non-
specific binding was blocked using Rodent Block R 
for cleaved caspase-3 (Biocare Medical) and Dako 
Protein Block (Agilent) for all other stains. Rabbit 
or goat serum without primary antibody were used 
as negative controls. ImmPACT DAB Substrate 
kit (Vector Laboratories) was used for chromogen 
staining. Sections were counterstained with NucRed 
Dead 647 (Thermo Fisher Scientific) for collagen VI 
and toluidine blue for all other stains. A blinded 
user analyzed two sections from each specimen that 
were 60 μm apart from each other and values were 
averaged. A total of 6-8 animals per group were used.
 200× images of the origin, midsubstance and 
insertion (tibial end) were analyzed using ImageJ 
(Schneider et al., 2012). As previously described 
(Andarawis-Puri et al., 2014; Bell et al., 2015), 
regions for analysis at the origin and insertion were 
determined by outlining a trapezoid that bordered 
the tendon, fibrocartilage and tendon surface. 
Midsubstance area for analysis was determined 
by calculating tendon midpoint and capturing two 
columns of images throughout the full thickness. 
Negative and positive caspase-3 cells were counted 
to determine live cell density [reflective of live cells 
and indicated by cleaved caspase-3 negative cells/
area (mm2)], apoptotic cell ratio (cleaved caspase-3 
positive/total cells, where total cells equal live cells 
plus apoptotic cells) and total cell density [total 
cells/area (mm2)]. Positive and total procollagen I, 
procollagen II, collagen VI, hyaluronan, LOX and 
ROMO1 cells were counted to determine positive 
cell ratio (positive/total cells).
 Mechanical testing was used to determine the 
effect of inhibition of apoptosis on the mechanical 
properties of fatigue-damaged tendons. Animals 
were sacrificed 6 weeks post-fatigue-loading and 
stored at − 20 °C. Fatigue loading leads to an 
immediate 20 % stiffness loss that is not recovered 
out until at least 6 weeks, suggesting that the effect 
of fatigue loading on the macroscopic mechanical 
properties would be similar at any time point within 
this time course (Andarawis-Puri and Flatow, 2011). 
However, since production of ECM proteins and 
their incorporation into the matrix can take several 
weeks (Xue and Jackson, 2015), the evaluation of 
the mechanical properties was carried out 6 weeks 
after fatigue loading. At time of testing, the patella-
patellar tendon-tibia unit for both fatigue-loaded and 
contralateral limb was harvested and the tibia was 
potted in poly(methyl methacrylate) bone cement. 
Cross-sectional area was calculated by multiplying 
the average width of three measurements along the 
length of the tendon by the thickness of the tendon, 
as measured using a digital caliper with a ~ 2 N load 
on the tendon. In a phosphate-buffered saline bath, 
the potted tibia was secured to the base and the 
patella was clamped. Tendons were loaded with a 
2 N preload for 1 min. A stress relaxation test was 
conducted by ramping to 5 % strain at 5 %/s and 
held for 300 s. After a 300 s recovery, the tendons 
were pulled to failure at a rate of 0.3 %/s. A custom 
Matlab program was used to calculate stiffness and 
modulus. Cross-sectional area, stiffness, maximum 
load, modulus and maximum stress were reported.
 For IHC analysis, Student’s t-tests were utilized 
to compare the inhibitor and the respective DMSO 
carrier control group. Inhibitor groups were 
normalized by their respective DMSO carrier control 
and non-parametric t-tests (Mann-Whitney) were 
used to compare normalized values over time. For 
mechanical assessment, the contralateral limbs from 
each group were first compared by Student’s t-test 
and, subsequently, pooled, since there were no 
differences. ANOVA with Tukey’s post-hoc tests was 
used to compare DMSO carrier, apoptosis inhibitor 
and contralateral controls. Significance was set at 
a p ≤ 0.05. Due to the nature of animal work and 
biological variability, trends were also reported, 
which were set to b p ≤ 0.1. Figures depict averages 
and standard deviations.
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observed after 2 d of systemic inhibition at the origin 
(p = 0.07) and insertion (p = 0.1). Consistent with these 
findings, 2 d of apoptosis inhibition led to a decrease 
in live cell density at day 14 in the origin (p = 0.07) and 
at day 7 in the midsubstance (p = 0.09). Additionally, 
apoptosis inhibition decreased live cell density at 
day 7 as compared to day 14 in the midsubstance 
(p = 0.07).
5 d injection
As hypothesized, 5 d of apoptosis inhibition increased 
live cells in the midsubstance and insertion (p = 0.02 
and 0.05, respectively, Fig. 1e and Table 1). This 
increase in live cell density returned to baseline for 
both the midsubstance (p = 0.02) and insertion (p = 0.1) 
at day 14. There were no significant differences in 
apoptotic cell ratio between the apoptosis inhibition 
and DMSO carrier control groups and between day 
7 and day 14 (Fig. 1d).
2 d versus 5 d of injection
As expected, live cell density was higher at day 
7 for 5 d than 2 d of apoptosis inhibition in the 
midsubstance (p = 0.001), with a trend supporting 
similar findings in the insertion (p = 0.07) (Fig. 2 
and Table 1). Similarly, at day 14, live cell ratio was 
higher for 5 d than 2 d of apoptosis inhibition in the 
origin (p = 0.05). Furthermore, there was an increase 
in total cell density (p = 0.01) at day 7 with 5 d vs. 2 d 
of injection. Interestingly, the comparison of 2 and 5 d 
of DMSO injections showed a decrease in apoptotic 
Results
First, whether apoptosis could be effectively inhibited 
in fatigue-damaged tendons was addressed using 
a systemic injection of QVD-OPh. Contrary to the 
working hypothesis, 2 d of apoptosis inhibition 
increased apoptosis at day 14 in the midsubstance (Fig. 
1a). However, supporting the working hypothesis, 
5 d of apoptosis inhibition led to an increase in live 
cell density in the midsubstance and insertion at day 
7 (Fig. 1e), which was modulated back to DMSO 
carrier control levels at day 14. Next, whether a 
larger population of cells produced key ECM and 
PCM proteins was addressed and the 5 d injection 
group, wherein inhibition of apoptosis was effective, 
was evaluated. Surprisingly, despite a promising 
initial increase in some regions in procollagen I and 
collagen VI, inhibition of apoptosis caused an increase 
in oxidative stress and ultimately led to further 
deterioration of mechanical properties of fatigue-
damaged tendons. The details of these findings are 
discussed below.
Dosage response of systemic pan-caspase 
inhibition on apoptotic activity
2 d injection
Contrary to what was hypothesized, 2 d of apoptosis 
inhibition increased apoptosis at day 14 in the 
midsubstance, as measured by apoptotic cell ratio 
(p = 0.05, Fig. 1a) and apoptotic cell density (p = 0.05) 
(Table 1). In addition, a similar trend at day 14 was 
Fig. 1. Effect of 2 and 5 days of inhibition of apoptosis on apoptotic activity. With 2 d of injections, (a) 
there was a general increase in apoptotic cell ratio at day 14 and (b) a decrease in live cell density at days 
7 and 14. (c) Representative midsubstance images of cleaved caspase-3 for 2 d of injection at day 7 and 14, 
showing increased apoptotic (brown) cells for the apoptosis inhibitor at day 14. With 5 d of injection, (d) 
there was no changes in apoptotic cell ratio, however, (e) a general increase in live cell density at day 7 was 
observed. (f) Representative midsubstance images of cleaved caspase-3 for 5 d of injection at day 7 and 
14, showing increased live (blue) cells for the apoptosis inhibitor at day 7. Arrows show positive staining.
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Fig. 2. 5 days of apoptosis injection increased live cell density. Live cell density was higher for 5 d as 
compared to 2 d of injection at (a) day 7 and at (b) day 14. (c) 5 d of injection increased total cell density 
at day 7.
Fig. 3. Decrease in mechanical properties caused by inhibition of apoptosis. (a) Fatigue loading and 
subsequent inhibition of apoptosis did not lead to changes in cross-sectional area. (b) Inhibition of apoptosis 
increased stress relaxation (%) as compared to contralateral and carrier control. Fatigue loading led to a 
decrease in (c) max load and (d) stiffness. (d) Inhibition of apoptosis led to a further decrease in stiffness 
as compared to carrier control.
cell density in the origin and midsubstance with the 
longer dosage (Table 1).
Effects of 5 d of apoptotic inhibition injections on 
tendon remodeling
Mechanical properties
Fatigue loading led to the expected decrease in 
stiffness (p = 0.04) and maximum load (p = 0.1) for 
the DMSO carrier control group when compared to 
the contralateral uninjured control at 6 weeks post-
fatigue-loading. Unexpectedly, 5 d of inhibition of 
apoptosis also led to a decrease in stiffness (p < 0.0001) 
and maximum load (p = 0.02) and an increase in 
percent relaxation (p = 0.0006) when compared to the 
contralateral control. Further comparison between 
the inhibitor and the carrier control showed that 
5 d of apoptosis inhibition significantly decreased 
the stiffness and increased the percent relaxation 
(p = 0.03) when compared to the DMSO carrier 
(p = 0.02). There was no effect from fatigue loading 
50 www.ecmjournal.org
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on the cross-sectional area for either group (p = 0.16) 
(Fig. 3). Consequently, modulus and maximum stress 
exhibited similar behavior to stiffness and maximum 
load, respectively (data not shown).
Extracellular matrix proteins
As hypothesized, in the origin, 5 d of apoptosis 
inhibition led to a higher positive cell ratio for 
procollagen I at day 7 when compared to day 14 
(p = 0.03) and to DMSO control (p = 0.05) (Fig. 4). 
Unexpectedly, there was no significant effect of 
apoptosis inhibition on procollagen I in either the 
midsubstance or the insertion at day 7 or 14. To 
provide further context, a representative lower 
magnification image of procollagen I is shown in 
Fig. 10a.
 Procollagen II was modulated by inhibition of 
apoptosis in the midsubstance only. More specifically, 
apoptosis inhibition decreased procollagen-II-
positive cell ratio in the midsubstance as compared 
to DMSO carrier (p = 0.1) at day 14. A lower positive 
cell ratio for procollagen II was found for the 5 d 
inhibition group at day 14 in comparison to day 7 
in the origin (p = 0.05) and insertion (p = 0.1) (Fig. 5). 
To provide further context, a representative lower 
magnification image of procollagen II is shown in 
Fig. 10b.
 Unexpectedly, inhibition of apoptosis had no 
effect on LOX, an ECM cross-linker, in the origin, 
midsubstance or insertion (Fig. 6). To provide further 
context, a representative lower magnification image 
of LOX is shown in Fig. 10c.
Pericellular matrix proteins
Surprisingly, apoptosis inhibition had no effects on 
collagen VI in the origin or midsubstance. However, 
as hypothesized, 5 d of apoptosis inhibition led to an 
increase in collagen-VI-positive cell ratio at day 7 as 
compared to DMSO carrier (p = 0.05) and to the effect 
of the inhibitor at day 14 (p = 0.05) (Fig. 7). To provide 
Fig. 4. Inhibiting apoptosis increased procollagen I. (a) Procollagen I was increased in the origin at day 
7. (b) Representative origin images of procollagen I for 5 d of injection at day 7 and 14. Arrows show 
positive staining.
Fig. 5. Inhibiting apoptosis increased procollagen II. (a) Procollagen II was generally increased at day 
7 as compared to day 14. (b) Representative insertion images of procollagen II for 5 d of injection at day 
7 and day 14. Arrows show positive staining.
R Bell et al.                                                                                             Inhibiting apoptosis exacerbates tendon damage
51 www.ecmjournal.org
further context, a representative lower magnification 
image of collagen VI is shown in Fig. 10d.
 Contrary to the working hypothesis, apoptosis 
inhibition had no effect on hyaluronan at the origin. 
In addition, apoptosis inhibition led to an unexpected 
decrease in hyaluronan-positive cell ratio in the 
midsubstance (p = 0.1) and insertion (p = 0.1) (Fig. 8). 
To provide further context, a representative lower 
magnification image of hyaluronan is shown in Fig. 
10e.
Cellular stress markers
Contrary to the working hypothesis, in the origin, 
inhibition of apoptosis led to an increase in ROMO1-
positive cell ratio at day 7 when compared to DMSO 
carrier (p = 0.05) and to the effect of the inhibitor at 
day 14 (p = 0.03). Similarly, in the insertion, apoptosis 
inhibition increased ROMO1-positive cell ratio at day 
7 as compared to DMSO carrier control (p = 0.06). 
Inhibition of apoptosis had no effect on ROMO1 in the 
midsubstance (Fig. 9). To provide further context, a 
representative lower magnification image of ROMO1 
is shown in Fig. 10f.
Discussion
While clinical biopsies of late stage tendinopathy 
show increased apoptotic activity (Lian et al., 
2007), those findings do not demonstrate a role for 
apoptosis in pathogenesis of tendinopathy. Previous 
studies show a direct correlation between severity 
of damage-induced, increased apoptotic activity 
and inhibition of remodeling genes, suggesting that 
apoptosis may be implicated in the pathogenesis 
of tendinopathy (Andarawis-Puri et al., 2012b; 
Andarawis-Puri et al., 2014). The working hypothesis 
was that non-damaged cells in fatigue-damaged 
tendons likely undergo apoptosis because of their 
altered loading environment that results from the 
matrix damage. Thus, the premise of the current 
study was that preventing cells in damaged matrix 
from undergoing apoptosis would prompt them 
to modulate their microenvironment to promote 
survival and ultimately promote matrix repair. In 
the present study, the effect of apoptosis inhibition 
on the ratio of cells positive for PCM proteins 
(indicative of changes into the microenvironment of 
the cells) and ECM (indicative of remodeling) and 
the resulting mechanical properties were evaluated. 
Two short durations of systemic pan caspase inhibitor 
[shorter (2 d) and longer (5 d)] were used to mitigate 
apoptotic activity, as it was expected that complete 
inhibition of apoptosis, as might be achieved by 
very long durations, might also have detrimental 
effects. The apoptosis inhibitor was dissolved in 
DMSO carrier and consequently, the effect of the 
inhibitor on fatigue-loaded tendons was determined 
through comparison with fatigue-loaded animals that 
received the DMSO carrier control. While DMSO use 
results in cytotoxicity (Galvao et al., 2014), the used 
concentration of DMSO was based on a previous 
study of apoptosis inhibition in bone, brain, spinal 
cord and heart (Keoni and Brown, 2015), suggesting 
a limited confounding effect of DMSO on cell death. 
Interestingly, comparison of the effect of 2 versus 
5 d of DMSO injections in fatigue-damaged tendons 
showed a surprising general decrease in apoptosis 
with the longer period of DMSO injection. While 
unexpected, a study by Banič et al. (2011) on cells 
in culture shows that DMSO can contribute to 
prolonged inactivation of the apoptosis pathways. 
Alternatively, the decrease in apoptosis (or increase 
in live cells) associated with 5 d versus 2 d of injections 
could be a feedback loop in response to an earlier 
rise in apoptosis. Regardless, normalizing the effect 
of the apoptotic inhibitor (in DMSO carrier) to the 
DMSO on fatigue-loaded control took into account 
the effect of DMSO, allowing for isolation of the effect 
of the inhibitor.
Fig. 6. Inhibiting apoptosis caused no changes in LOX. (a) Inhibition of apoptosis in fatigue-damaged 
tendons had no effect on LOX. (b) Representative insertion images of LOX for 5 d of injection at day 7 and 
day 14. Arrows show positive staining.
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 The longer dosage of inhibitor more effectively 
inhibited apoptosis, as indicated by increased live 
cell density at day 7, particularly in the midsubstance 
and insertion. Additionally, since there was no 
change in apoptotic cell ratio, the results suggested 
that the longer dosage of the inhibitor was both 
inhibiting apoptosis and promoting proliferation or 
cell recruitment. This was consistent with a study by 
Hua et al. (2015) showing that inhibition of caspase-3 
pathways modulates cell cycles and can prompt an 
increase in the number of cells entering S-phase, 
ultimately leading to an increase in proliferation. In 
contrast, the shorter duration of apoptosis inhibitor 
caused a delayed and enhanced apoptotic response 
14 d after chronic injury, suggesting that very short 
durations were ineffective at allowing cells to modify 
their microenvironment to mitigate the effect of the 
damaged matrix.
 Effective inhibition of apoptosis was manifested 
as an increase in live cell density in the midsubstance 
and insertion. Interestingly, inhibition of apoptosis 
led to an increase in procollagen I in the origin at 
day 7 despite the absence of any increase in live 
cell density in this region. Since a pan caspase 
inhibitor was utilized, it was possible that cells 
that were not yet committed to undergo apoptosis 
(as indicated by caspase-3) underwent inhibition 
of other caspases that are earlier in the apoptosis 
pathway. These cells were likely still in a stressed 
state, as indicated by the accompanying increase 
in ROMO1, prompting synthesis of collagen I to 
stabilize their surrounding damaged ECM. Since 
collagen I is essential for imparting the tendon 
with its capacity to bear tensile loads (Screen et 
al., 2015), this observed increase was expected to 
ultimately lead to improved mechanical properties. 
Fig. 7. Inhibiting apoptosis increased collagen VI. (a) Collagen VI was increased in the insertion at day 
7. (b) Representative insertion images of collagen VI for 5 d of injection at day 7 and day 14. Arrows 
showing positive staining.
Fig. 8. Inhibiting apoptosis decreased hyaluronan. (a) Hyaluronan was generally decreased at day 7. 
(b) Representative insertion images of hyaluronan for 5 d of injection at day 7 and day 14. Arrows show 
positive staining.
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Furthermore, effective inhibition of apoptosis led to 
a decrease in procollagen II in the midsubstance at 
day 14. Collagen II is a main constituent of tissues 
that predominantly bear compressive loads and its 
increase in the midsubstance is typically associated 
with degeneration (Waggett et al., 1998). Thus, the 
observed decrease in procollagen II associated with 
inhibition of apoptosis was initially interpreted 
as an indicator of ECM repair. However, despite 
these early changes in ECM protein synthesis that 
were consistent with remodeling of ECM damage, 
inhibition of apoptosis was found to lead ultimately 
to further deterioration of mechanical properties 6 
weeks post-fatigue-loading.
 There are several possible explanations for the 
absence of an improvement in mechanical properties 
after inhibition of apoptosis, despite the observed 
modulation in procollagen I and II. A decrease in 
procollagen II in the midsubstance might not be 
sufficient to overcome the effect of the damage in 
the insertion. Similarly, procollagen I was increased 
only in the origin, suggesting that the effect of the 
damage in the midsubstance and the highly damaged 
insertion region could overwhelm the observed 
remodeling in the origin. Furthermore, increased 
procollagen I might not lead to effective incorporation 
of collagen I into the matrix. This notion was further 
supported by the lack of change in LOX, a protein 
Fig. 9. Inhibiting apoptosis increased ROMO1. (a) ROMO1 was generally increased at day 7. (b) 
Representative origin images of hyaluronan for 5 d of injection at day 7 and day 14. Arrows show positive 
staining.
Fig. 10. Overall effect of inhibiting apoptosis on key proteins. Representative images of 5 d injection at day 
7 or 14 showing (a) increased procollagen I for the apoptosis inhibitor at day 7, (b) increased procollagen 
II for the apoptosis inhibitor at day 7, (c) no changes in LOX, (d) increased collagen VI for the apoptosis 
inhibitor at day 7, (e) decreased hyaluronan for the apoptosis inhibitor at day 7 and (f) increased ROMO1 
for the apoptosis inhibitor at day 7. Arrows show positive staining.
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that plays an essential role in collagen fibril formation 
and ECM crosslinking (Herchenhan et al., 2015; 
Smith-Mungo and Kagan, 1998). Consequently, the 
lack of modulation of LOX from apoptosis inhibition 
suggested no new collagen formation.
 Studies on cartilage (Fehrenbacher et al., 2003; 
Li et al., 2013; McCulloch et al., 2014) motivated the 
hypothesis that cells in regions of damaged tendon 
ECM will form an enhanced PCM to maintain 
mechanical stimulation, thereby reducing cell stress 
and protecting against apoptosis. Interestingly, the 
results of this study show an increase in collagen 
VI that was not associated with any increase in 
procollagen I or any other change that could be 
indicative of a remodeling attempt. In fact, ROMO1, 
a stress marker, was also concurrently increased 
in the insertion region. Taken together, these data 
suggested that the excessive ECM damage in the 
insertion region, along with the complex loading 
environment, could have prompted an increase in 
collagen VI, which was ineffective at normalizing 
the microenvironment of the cells. Collagen VI is 
typically associated with regions that experience 
complex loads, such as the insertion (Waggett et al., 
1998). Thus, other PCM proteins, such as hyaluronan, 
were expected to be more critical in the tensile load-
bearing midsubstance. Surprisingly, hyaluronan 
was decreased in the midsubstance and insertion. 
While unexpected, Yamazaki et al. (2003) show that 
cyclic stretch of chondrocytes in cartilage leads to 
an increase in reactive oxygen species (ROS) that 
depolymerize hyaluronan, providing a possible 
explanation for the observed decrease in hyaluronan.
 There are several possible explanations for the 
deterioration in mechanical properties of fatigue-
damaged tendons that resulted from inhibition 
of apoptosis. Prevention of apoptosis through the 
caspase pathways could prompt over compensation 
of other pathways, such as programmed cell necrosis 
through the autophagy pathway (Zhao et al., 2015). 
Consistent with the results of the current study, an 
increased ROS production is reported. Studies of 
intervertebral disc implicate ROS production in disc 
degeneration through a catabolic effect via mitogen-
activated protein kinases (MAPKs) signaling and 
increase matrix metalloproteinases activity (Li et al., 
2012; Suzuki et al., 2015). A similar mechanism might 
be implicated in fatigue-damaged tendons.
 Cell-ECM interactions, through agents such as 
integrins, connexins and cadherins, regulate cell 
homeostasis by communicating chemical, structural 
and mechanical cues between the cell and the 
surrounding ECM environment. Disruptions to 
such interactions may alter cell signaling, leading 
to either a reparative (anabolic) or pathological 
(catabolic) effect by altering cell metabolism (for 
example, protein production) and/or cell fate (for 
example, proliferation, differentiation or apoptosis) 
(Humphrey et al., 2014; Qi et al., 2011). The current 
study showed that apoptosis inhibition enabled 
tenocytes to produce matrix proteins but the transient 
effects at the origin and insertion suggested that 
production of more matrix proteins was required and/
or that cell-ECM interactions needed to be restored. 
Combining apoptosis inhibition with another 
therapeutic that restores cell-ECM interactions, such 
as physiologic mechanical loading (Popov et al., 
2015) or exercise, might be optimal for long-term cell 
survival and tissue repair.
 One limitation of this study was that the pan-
caspase inhibitor was systemically administered, 
therefore, the amount of inhibitor that was taken 
up by each region of the tendon could not be 
directly assessed. For instance, vascularity, which 
typically varies among the insertion, origin and 
midsubstance (Pufe et al., 2005), might be further 
altered non-uniformly by fatigue loading, impacting 
the capacity of each region to uptake the drug. While 
this limitation did not affect the conclusions drawn in 
the current study, a local apoptosis delivery method 
and a full dosage-response study would provide 
further insight. Another limitation was that it was 
not possible to track which cells were inhibited from 
undergoing apoptosis, to determine how their protein 
production was altered. Future studies will utilize 
multiple staining techniques to assess levels of several 
proteins for the same cells at a given timepoint. Lastly, 
while previous studies show a correlation between 
ECM damage and apoptosis (Andarawis-Puri N et al., 
2014) , the nature of the altered loading environment 
associated with ECM damage that prompts apoptosis 
remains unknown and should be evaluated in future 
studies. For instance, cells residing in severely 
damage ECM are likely under-loaded due to loss of 
cell-ECM interactions. Conversely, prior to reaching 
the under-loaded state, cells in damaged ECM were 
likely overloaded due to plastic deformation of 
collagen fibers. Understanding the loading state that 
prompts apoptosis would provide further insight 
into the mechanotransduction pathways that are 
associated with aberrant micro-mechanical cellular 
environments.
 In conclusion, inhibiting apoptosis, thereby 
forcing cells to stay alive in the presence of ECM 
damage, led to further degeneration, despite some 
early indicators of remodeling. While inhibition 
of apoptosis might still be an effective approach 
for promoting repair of fatigue-damaged tendons, 
a different approach, wherein cell survival is the 
outcome of a modulated micro-environment of the 
cells should be considered.
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Discussion with Reviewer
Keri Gardner: Changes in collagen and pro collagens 
may be due to increased collagenases because of 
microscopic damage (Lavagnino et al., 2006 additional 
reference). What is the authors opinion about it?
Authors: The changes in collagen levels could be 
caused by local collagenase due to the fatigue-
damaged tendons. However, this phenomenon 
would be equally likely to occur in both the apoptosis 
inhibitor group and the DMSO carrier control 
group. Thus, any observed differences between the 
apoptosis inhibitor and DMSO control groups in the 
procollagens/collagens could only be attributed to the 
effect of blocking apoptosis.
Additional Reference
 Lavagnino M, Arnoczky SP, Egerbacher M, 
Gardner KL, Burns ME (2006) Isolated fibrillar 
damage in tendons stimulates local collagenase 
mRNA expression and protein synthesis. J Biomech 
39: 2355-2362.
Editor’s note: The Scientific Editor responsible for 
this paper was Juerg Gasser.
